Suchergebnisse - "Nicholas, Jacqueline"

PubPharm (7)

1

Satisfaction with alemtuzumab in relapsing multiple sclerosis patients : Results from the real-world PRO-ACT study

enthalten in: Multiple sclerosis journal - experimental, translational and clinical | 2022

von Wray, S. | Jacques, F. | Miller, T. | +11

2

Safety experience with continued exposure to ofatumumab in patients with relapsing forms of multiple sclerosis for up to 3.5 years

enthalten in: Multiple sclerosis (Houndmills, Basingstoke, England) | 2022

von Hauser, S. | Cross, A. | Winthrop, K. | +17

3

Employing Connectome-Based Models to Predict Working Memory in Multiple Sclerosis

enthalten in: Brain connectivity | 2022

von Manglani, H. | Fountain-Zaragoza, S. | Shankar, A. | +2

4

Rapid and sustained B-cell depletion with subcutaneous ofatumumab in relapsing multiple sclerosis : APLIOS, a randomized phase-2 study

enthalten in: Multiple sclerosis (Houndmills, Basingstoke, England) | 2022

von Bar-Or, A. | Wiendl, H. | Montalban, X. | +30

5

Harnessing Real-World Data to Inform Decision-Making : Multiple Sclerosis Partners Advancing Technology and Health Solutions (MS PATHS)

enthalten in: Frontiers in neurology | 2020

von Mowry, E. | Bermel, R. | Williams, J. | +22

6

First-line natalizumab in multiple sclerosis : rationale, patient selection, benefits and risks

enthalten in: Therapeutic advances in chronic disease | 2014

von Nicholas, J. | Racke, M. | Imitola, J. | +1

7

Design of oral agents for the management of multiple sclerosis : benefit and risk assessment for dimethyl fumarate

enthalten in: Drug design, development and therapy | 2014

von Nicholas, J. | Boster, A. | Imitola, J. | +2

1
[1]